Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Rabies Vaccines
Data from Crucell Holland BV provide new insights into rabies vaccines
January 21st, 2009
New research, 'First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity,' is the subject of a report. "Immediate passive immune prophylaxis as part of rabies post-exposure prophylaxis (PEP) often cannot be provided due to limited availability of human or equine rabies immunoglobulin (HRIG and ERIG, respectively). We report first clinical data from two phase I studies evaluating a monoclonal antibody cocktail CL184 against rabies," investigators in Leiden, Netherlands report. "The studies included healthy adult subjects in the USA and India and involved two parts. First, subjects received a...
Source: Vaccine Weekly (2009-01-21)
|
